Comparison of PathVysion and INFORM Fluorescence In Situ Hybridization Kits for Assessment of HER-2/neu Status in Breast Carcinoma

被引：0
|
作者：
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构：
[1] University of Illinois at Chicago,Department of Pathology
来源：
Molecular Diagnosis | 2000年 / 5卷 / 3期
关键词：
PathVysion; INFORM; prognosis; immunohistochemistry;
D O I：
10.1007/BF03262076
中图分类号：
学科分类号：
摘要：
Background: Fluorescence in situ hybridization is advocated for precise assessment of HER-2/neu status in breast carcinoma; however, few objective data compare available kits for clinical laboratories contemplating development of the test.
引用
收藏
页码：193 / 197
页数：4
相关论文
共 50 条
12345